Article (Published version) (1.5 MB) - 
Limited access to UNIGEOther version: http://www.omicsonline.org/2155-6156/2155-6156-2-126.digital/2155-6156-2-126.html
Highlights
Home
Titles listImeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes
Titles listImeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes
Scientific Article
unige:47301 
 |
Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes |
|
| Authors | ||
| Published in | Journal of Diabetes and Metabolism. 2011, vol. 2, no. 4 | |
| Identifiers | ||
| Full text |
Article (Published version) (1.5 MB) - Limited access to UNIGE Other version: http://www.omicsonline.org/2155-6156/2155-6156-2-126.digital/2155-6156-2-126.html |
|
| Structures | ||
| Citation (ISO format) | FOUQUERAY, Pascale et al. Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes. In: Journal of Diabetes and Metabolism, 2011, vol. 2, n° 4. doi: 10.4172/2155-6156.1000126 https://archive-ouverte.unige.ch/unige:47301 |
489 hits 
1 download 
Contact an author
Update